Fetal transfusion therapy

Obstetrical and Gynecological Survey

Volumn 51, Issue 3, 1996, Pages 181-192

  Skupski, Daniel W ^a   Wolf, Carl F W ^a   Bussel, James B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RHESUS ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; AMNIOCENTESIS; ANEMIA; CORDOCENTESIS; ERYTHROCYTE TRANSFUSION; FETUS; FETUS DISEASE; FETUS HYDROPS; HEMATOPOIETIC STEM CELL; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; NEWBORN HEMOLYTIC DISEASE; PARVOVIRUS; POLYMERASE CHAIN REACTION; REVIEW; RHESUS IMMUNIZATION; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VIRUS INFECTION;

ANEMIA; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION, INTRAUTERINE; FETAL DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; THROMBOCYTOPENIA;

EID: 0029864312     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199603000-00022     Document Type: Review

References (73)

1. Plater F. Observationum Basle, 1641, 748.
2. Ballantyne JW. The diseases and deformities of the foetus, Oliver and Boyd, 1892-1895.
3. Landsteiner K, Weiner AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940;43:223.
4. Levine P. Isoimmunization in pregnancy and the pathogenesis of erythroblastosis fetalis. In: Karsner HT, Hooker SB, eds. 1941 Yearbook of Pathology and Immunology. Chicago: Yearbook Publishers, 1941, p 505.
5. Liley AW. Liquor amnii analysis in the management of pregnancy complicated by rhesus immunization. Am J Obstet Gynecol 1961;82:1359.
6. Liley AW. Intrauterine transfusion of fetus in hemolytic disease. Br Med J 1963;2:1107.
7. Rodeck CH, Holman CA, Karicki J et al. Direct intravascular fetal blood transfusion by fetoscopy in severe rhesus isoimmunization. Lancet 1981;1:625.
8. Rodeck CH, Nicolaides KH, Warsof SL et al. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 1941;150:769.
9. 2 globulin antibody preparation. Fed Proc 1963;22:374.
10. Freda VJ, Gorman JG, Pollack W et al. Prevention of Rh hemolytic disease: Ten years' clinical experience with Rh immune globulin. N Engl J Med 1975;292:1014.
11. Bowman JM, Friesen AD, Pollack JM et al. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. Can Med Assoc J 1980;123:1121-1127.
12. Nicolaides KH. Management of red blood cell isoimmunized pregnancies. Chapt 146. In: Chervenak FA, Isaacson GC, Campbell S, eds. Ultrasound in Obstetrics and Gynecology. Boston: Little, Brown & Company, 1993.
13. Bowman JM, Pollock JM. Antenatal Rh prophylaxis: 28 week gestation service program. Can Med Assoc J 1978;118:627.
14. Prevention of D Isoimmunization. The American College of Obstetricians and Gynecologists Technical Bulletin 147; Washington, DC; October, 1990.
15. de Almeida V, Bowman JM. Massive fetomaternal hemorrhage: Manitoba experience. Obstet Gynecol 1994;83:323-328.
16. Bowell P, Wainscoat JS, Peto TE et al. Maternal anti-D concentrations and outcome in rhesus hemolytic disease of the newborn. Br Med J 1982;2:85(6338)327.
17. Leggat HM, Gibson JM, Barron SL et al. Anti-Keil in pregnancy. Br J Obstet Gynaecol 1991;98:162-165.
18. Mollison PL, Engelfriet CP, Contreras M. Hemolytic disease of the fetus and newborn. In: Mollison PL, ed. Blood Transfusion in Clinical Medicine, 9th ed. Oxford: Blackwell Scientific Publications, 1993, p 545.
19. Bowman JM. Hemolytic disease (erythroblastosis fetalis). In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 3rd ed. Philadelphia: WB Saunders Co, 1994, pp 739-741.
20. Marsh WL, Reid ME, Kuriyan M et al. (eds). A Handbook of Clinical and Laboratory Practices in the Transfusion of Red Blood Cells. Monita, VA: Monita Press, 1993.
21. Tarczy-Hornoch P, Hodson WA. Neonatology (editorial). J Am Med Assoc 1994;271:1682-1684.
22. Mollison PL. Hemolytic disease of the newborn (Chapt 16). In: Mollison PL, ed. Blood Transfusion in Clinical Medicine, 6th ed. Oxford: Blackwell Scientific Publications, 1979, pp 675-677.
23. Nicolaides KH, Rodeck CH, Mibashan MD et al. Have Liley charts outlived their usefulness? Am J Obstet Gynecol 1986; 155:90.
24. Bennett PR, Le Van Kim C, Colin Y et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993;329:607-610.
25. Medical Research Council: Diagnosis of genetic disease by amniocentesis during the second trimester of pregnancy. Report No. 5, 1977.
26. Lowe CU, Alexander D, Bryla D et al. The NICHD amniocentesis registry: The safety and accuracy of midtrimester amniocentesis. U.S. Department of Health, Education and Welfare, DHEW Publications No. (NIH) 78-190, 1978.
27. Medical Research Council: An assessment of the hazards of amniocentesis. Br J Obstet Gynaecol 1978;85:1.
28. Ghidini A, Sepulveda W, Lockwood CJ et al. Complications of fetal blood sampling. Am J Obstet Gynecol 1993;168:1339-1344.
29. Duchatel F, Aury JF, Mennesson B et al. Complications of ultrasound-guided percutaneous umbilical blood sampling: analysis of a series of 341 cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 1993;52:95-104.
30. Laifer SA, Kuller JA, Hill LM. Rapid assessment of fetal hemoglobin concentration with the HemoCue system. Obstet Gynecol 1990;76:723-724.
31. Seeds JW, Bowes WA, Chescheir NC. Echogenic venous turbulence is a critical feature of successful intravascular intrauterine transfusion. Obstet Gynecol 1989;73:488-490.
32. Bowman JM, Pollock JM, Peterson LE et al. Fetomaternal hemorrhage following funipuncture: Increase in severity of maternal red cell alloimmunization. Obstet Gynecol 1994;84: 839-843.
33. Gonsoulin WJ, Moise KJ, Milam JD et al. Serial maternal blood donations for intrauterine transfusion. Obstet Gynecol 1990; 75:158-162.
34. DePalma L, Criss VR, Roseff SD et al. Formation of alloanti-E in an 11-week-old infant. Transfusion 1991;31:Suppl 52S.
35. Moise KJ, Mari G, Fisher DJ et al. Acute fetal hemodynamic alterations after intrauterine transfusion for treatment of severe red blood cell alloimmunization. Am J Obstet Gynecol 1990;163:776-784.
36. Nicolaides KH, Clewell WH, Mibashan RS et al. Fetal hemoglobin measurement in the assessment of red cell isoimmunization. Lancet 1988, May 14, pp 1073-1075.
37. MacGregor SN, Socol ML, Pielet BW et al. Prediction of fetoplacental blood volume in isoimmunized pregnancy. Am J Obstet Gynecol 1988;159:1493-1497.
38. Queenan JT. Amniotic fluid analysis. In Modern management of the Rh problem, 2nd Ed. New York: Harper & Row, 1977, pp 73-129.
39. Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987;157:50-53.
40. Copel JA, Grannum PA, Harrison D et al. The use of pancuronium bromide to produce fetal paralysis during intravascular transfusion. Am J Obstet Gynecol 1988;158:170-171.
41. Bernstein HH, Chitkara U, Plosker H et al. Use of atracurium besylate to arrest fetal activity during intrauterine transfusions. Obstet Gynecol 1988;72:813.
42. MacGregor SN, Socol ML, Pielet BW et al. Prediction of hematocrit decline after intravascular fetal transfusion. Am J Obstet Gynecol 1989;161:1491-1493.
43. Skupski D, Wolf CFW, Bussel JB. Fetal and perinatal transfusion therapy. In: Strauss RG, ed, Clinical Practice of Transfusion Medicine. New York: Churchill Livingstone, 1995.
44. Millard DD, Gidding SS, Socol ML et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990;117:44 7-454.
45. Scaradavou A, Inglis S, Peterson P et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietin to treat the late anemia. J Pediatr 1993;123:279-284.
46. Carrington D, Gilmore DH, Whittle MJ et al. Maternal serum alpha-fetoprotein: A marker of fetal aplastic crises during intrauterine human parvovirus infection. Lancet 1987;1:433-435.
47. Schwarz TF, Roggendorf M, Hottentrager B et al. Human parvovirus B19 infection in pregnancy. Lancet 1988;2:566-567.
48. Anand A, Gray ES, Brown T et al. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-6.
49. Kaplan C, Morel-Kopp MC, Kroll H et al. HPA-5b [Br(a)] neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991;78:425-429.
50. Shulman NR, Marder VJ, Heller MC et al. Platelet and leukocyte isoantigens and their antibodies: Serologic, physiologic, and clinical studies. Prog Hematol 1964;4:222-304.
51. Bussel JB, Berkowitz RL, McFarland JG et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988;319:1374-1378.
52. Kaplan C, Daffos F, Forestier F et al. Management of alloimmune thrombocytopenia: Antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988;72:340-343.
53. Giovangrandi Y, Daffos F, Kaplan C et al. Very early intracranial hemorrhage in alloimmune fetal thrombocytopenia (lettr). Lancet 1990;336(8710):310.
54. Lynch L, Bussel JB, McFarland JG et al. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol 1992;80:67-71.
55. Waters A, Murphy M, Hambley H et al. Management of alloimmune thrombocytopenia in the fetus and neonate. In: Nance SJ, Ed. Clinical and Basic Science Aspects of Immunohematology. Arlington, VA, American Association of Blood Banks, 1991, pp 155-177.
56. Murphy MF, Waters AH, Doughty A et al. Antenatal management of fetomaternal alloimmune thrombocytopenia - Report of 15 affected pregnancies. Transfus Med 1994;4:281-292.
57. Kroll H, Kiefel V, Giers G et al. Maternal intravenous immunoglobulin treatment does not prevent intracranial hemorrhage in fetal alloimmune thrombocytopenia. Transfus Med 1994;4: 293-296.
58. Murphy MF, Pullon HWH, Metcalfe P et al. Management of fetal alloimmune thrombocytopenia by weekly in utero platelet transfusions. Vox Sang 1990;58:45-49.
59. Murphy MF, Metcalfe P, Waters AH et al. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Blood 1993;81:2174-2179.
60. Hillyer CD, Emmens RK, Zago-Novaretti M et al. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: Filtration versus the use of seronegative donor units. Transfusion 1994;34:929-934.
61. Fowler KB, Stagno S, Pass RF et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-667.
62. Pineda AA, Zylstra VW, Clare DE et al. Viability and functional integrity of washed platelets. Transfusion 1989;29:524-527.
63. Rodeck CH, Roberts LJ. Successful treatment of fetal cardiac arrest by left ventricular exchange transfusion. Fetal Diagn Ther 1994;9:213-217.
64. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-1147.
65. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1990;163:1147-1150.
66. Bussel JB, Druzin ML, Cines DB et al. Thrombocytopenia in pregnancy (Lettr). Lancet 1991;337:251.
67. Kaplan C, Daffos F, Forestier F et al. Fetal platelet counts in thrombocytopenic pregnancy. Lancet 1990;336:979-982.
68. Samuels P, Bussel JB, Braitman LE et al. Estimate of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990;323:229-235.
69. Christiaens GC, Nieuwenhuis HK, von dem Borne AE et al. Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990; 97:893-898.
70. Cook RL, Miller RC, Katz VL et al. Immune thrombocytopenic purpura in pregnancy: A reappraisal of management. Obstet Gynecol 1991;78:578-583.
71. Weiner CP. Thrombocytopenia and cordocentesis (Lettr). Am J Obstet Gynecol 1989;161:1091-1092.
72. Weiner CP. Cordocentesis and immune cytopenia (Lettr). Am J Obstet Gynecol 1990;163:1371-1372.
73. Cowan MJ, Golbus M. In utero stem cell transplants for inherited diseases. Am J Pediatr Hematol Oncol 1994;16: 35-42.